Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Distigmine
2. Hexamarium
3. Pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis-1-methyl-, Dibromide
4. Ubretid
1. 15876-67-2
2. Ubretid
3. Ubritil
4. Distigmini Bromidum
5. Hexamarium
6. Bromure De Distigmine
7. Bromuro De Distigmina
8. Distigminebromide
9. Hexamarium Bromide
10. Bc 51
11. Distigmine Dibromide
12. Bc-51
13. 750f36op6j
14. 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium) Dibromide
15. (1-methylpyridin-1-ium-3-yl) N-methyl-n-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate;dibromide
16. 3,3'-(((hexane-1,6-diylbis(methylazanediyl))bis(carbonyl))bis(oxy))bis(1-methylpyridin-1-ium) Bromide
17. 3-hydroxy-1-methylpyridinium Bromide Hexamethylenebis-(n-methylcarbamate)
18. (1-methylpyridin-1-ium-3-yl) N-methyl-n-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate,dibromide
19. 3,3'-{hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridin-1-ium) Dibromide
20. Distigmini Bromidum [inn-latin]
21. Distigmine Bromide [inn:ban:jan]
22. Bromure De Distigmine [inn-french]
23. Einecs 240-013-0
24. Bromuro De Distigmina [inn-spanish]
25. Adcostigmine
26. Unii-750f36op6j
27. Ubretid (tn)
28. 3-hydroxy-1-methylpyridinium Bromide Hexamethylenebis(methylcarbamate)
29. Schembl148842
30. Distigmine Bromide [mi]
31. Chembl1098285
32. Distigmine Bromide [inn]
33. Distigmine Bromide [jan]
34. Chebi:31512
35. Distigmine Bromide (jp17/inn)
36. Dtxsid60935985
37. Distigmine Bromide [mart.]
38. Bcp16582
39. Distigmine Bromide [who-dd]
40. Mfcd00867188
41. Akos015914117
42. Pyridinium, 3-hydroxy-1-methyl-, Bromide, Hexamethylenebis(methylcarbamate)
43. Ac-8868
44. Pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis-1-methyl-, Dibromide
45. As-74357
46. Sy226319
47. Hy-119577
48. Cs-0070000
49. Ft-0718457
50. C72992
51. D01228
52. A855351
53. Q3277473
54. 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium)dibromide
55. 3,3'-{hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridinium) Dibromide
56. Hexamethylenebis(n-methylcarbaminoyl-1-methyl-3-hydroxypyridinium Bromide)
57. 1-methyl-3-{[methyl({6-[methyl({[(1-methylpyridin-1-ium-3-yl)oxy]carbonyl})amino]hexyl})carbamoyl]oxy}pyridin-1-ium Dibromide
58. 3,3-(((hexane-1,6-diylbis(methylazanediyl))bis(carbonyl))bis(oxy))bis(1-methylpyridin-1-ium) Bromide
59. Pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methyl-, Bromide (1:2)
Molecular Weight | 576.3 g/mol |
---|---|
Molecular Formula | C22H32Br2N4O4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Exact Mass | 576.07698 g/mol |
Monoisotopic Mass | 574.07903 g/mol |
Topological Polar Surface Area | 66.8 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 487 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Market Place
ABOUT THIS PAGE
A Distigmine Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Distigmine Bromide, including repackagers and relabelers. The FDA regulates Distigmine Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Distigmine Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Distigmine Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Distigmine Bromide supplier is an individual or a company that provides Distigmine Bromide active pharmaceutical ingredient (API) or Distigmine Bromide finished formulations upon request. The Distigmine Bromide suppliers may include Distigmine Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Distigmine Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Distigmine Bromide Drug Master File in Japan (Distigmine Bromide JDMF) empowers Distigmine Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Distigmine Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Distigmine Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Distigmine Bromide suppliers with JDMF on PharmaCompass.
Distigmine Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Distigmine Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Distigmine Bromide GMP manufacturer or Distigmine Bromide GMP API supplier for your needs.
A Distigmine Bromide CoA (Certificate of Analysis) is a formal document that attests to Distigmine Bromide's compliance with Distigmine Bromide specifications and serves as a tool for batch-level quality control.
Distigmine Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Distigmine Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Distigmine Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Distigmine Bromide EP), Distigmine Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Distigmine Bromide USP).
LOOKING FOR A SUPPLIER?